Uses, Dosage & Side Effects: Iclusig Tablet
Iclusig Tablet
| Generic name | ponatinib |
|---|---|
| Drug class | BCR-ABL tyrosine kinase inhibitor (TKI) |
| Forms | Tablet (10 mg, 15 mg, 30 mg, 45 mg) |
Iclusig is a prescription cancer medicine that comes as a tablet you swallow. It is used to treat certain blood cancers in adults, including chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL), especially when other similar medicines have not worked or could not be tolerated.
Read the full guideUses, dosage, side effects, precautions, and sources, written from the same verified facts.
General information, not medical advice
Your prescriber and the leaflet in your pack know your situation. This page does not.
- Follow your prescriber and the leaflet
- Don't start, stop, or change a dose on your own
- Doses and warnings differ by country and product
Took too much, or feel seriously unwell? Get urgent medical help now.
Facts checked by a personFull disclaimer
